Polymorphisms of the TP53 codon 72 and WRN codon 1367 in individuals from Northern Brazil with gastric adenocarcinoma

被引:0
|
作者
A. S. Khayat
L. Lobo Gatti
E. Moura Lima
P. P. de Assumpção
F. J. Nascimento Motta
M. L. Harada
C. Casartelli
S. L. Marques Payão
M. A. Cardoso Smith
R. R. Burbano
机构
[1] Campus Universitário do Guamá,Laboratório de Citogenética Humana, Departamento de Biologia, Centro de Ciências Biológicas
[2] Universidade Federal do Pará,Disciplina de Genética
[3] Universidade Federal de São Paulo,Departamento de Genética, Faculdade de Medicina de Ribeirão Preto
[4] Escola Paulista de Medicina,Serviço de Cirurgia
[5] Faculdade de Medicina de Marília,undefined
[6] Disciplinas de Genética e de Biologia Molecular,undefined
[7] Universidade de São Paulo,undefined
[8] Hospital Universitário João de Barros Barreto,undefined
[9] UFPA,undefined
来源
关键词
codon 72 polymorphisms; codon 1367 polymorphisms; Gastric cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Gastric cancer is the second most frequent type of neoplasia and also the second most common cause of death in the world. TP53 codon 72, which produces variant proteins with an arginine (Arg) or proline (Pro), has been reported to be associated with cancers of the lung, oesophagus, stomach and cervix. Werner’s syndrome (WS) is a premature ageing disease caused by a mutation in the WRN gene. The WRN protein acts as a DNA helicase and as an exonuclease. WRN codon 1367 produces variant proteins with an Arg or cysteine (Cys). This polymorphism has been studied, in order to understand the clinical impact of the molecular variants in WS and in age-related disorders. In the present study, the TP53 codon 72 and the WRN codon 1367 polymorphisms were investigated in 54 gastric adenocarcinoma patients (31 diffuse-type and 25 intestinal-type) and 54 controls. DNA samples were extracted, and PCR-RFLP was utilised for genotyping TP53 codon 72 and WRN codon 1367. The allele frequencies of the TP53 polymorphism were: Arg=0.74 and Pro=0.26. The allele frequencies of the WRN polymorphism were: Cys=0.73 and Arg=0.27. The crude genotypic frequencies in gastric cancer patients were similar to those of the controls, but in the WRN codon 1367 polymorphisms the mean age tended to be higher in the Arg/Arg genotypes. There also was an association, although not statistically significant, between the presence of Helicobacter pylori and the genotypes Cys/Cys and Cys/Arg and a higher percentage of cardia cancer among the Arg/Arg genotypes, and of non-cardia cancer among genotypes Cys/Cys and Cys/Arg. These findings may be a reflection of differences in the interaction between WRN codon 1367 polymorphisms and local factors in the stomach. To our knowledge, this is the first study to examine a genetic polymorphism of the WRN gene in cancer. The precise mechanisms of action of the TP53 and WRN polymorphisms involved in the aetiopathogeny of this disease need further investigation.
引用
收藏
页码:161 / 168
页数:7
相关论文
共 50 条
  • [31] Analysis of the codon 72 polymorphism of the TP53 gene in patients with endometriosis
    Lattuada, D
    Viganò, P
    Somigliana, E
    Abbiati, A
    Candiani, M
    Di Blasio, AM
    MOLECULAR HUMAN REPRODUCTION, 2004, 10 (09) : 651 - 654
  • [32] TP53 codon 72 polymorphism in adult soft tissue sarcomas
    Almeida, P. S. R.
    Manoel, W. J.
    Reis, A. A. S.
    Silva, E. R.
    Martins, E.
    Paiva, M. V. O.
    Fraga Junior, A. C.
    Saddi, V. A.
    GENETICS AND MOLECULAR RESEARCH, 2008, 7 (04) : 1344 - 1352
  • [33] TP53 codon 72 polymorphism is associated with age at onset of glioblastoma
    El Hallani, S.
    Ducray, F.
    Idbaih, A.
    Marie, Y.
    Boisselier, B.
    Colin, C.
    Laigle-Donadey, F.
    Rodero, M.
    Chinot, O.
    Thillet, J.
    Hoang-Xuan, K.
    Delattre, J. -Y.
    Sanson, M.
    NEUROLOGY, 2009, 72 (04) : 332 - 336
  • [34] Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population
    Mostaid, Md. Shaki
    Ahmed, Maizbha Uddin
    Islam, Mohammad Safiqul
    Bin Sayeed, Muhammad Shahdaat
    Hasnat, Abul
    TUMOR BIOLOGY, 2014, 35 (10) : 10309 - 10317
  • [35] Codon 72 polymorphisms in the tumor suppressor gene TP53 in patients with chronic myelogenous leukemia.
    Bergamaschi, G
    Merante, S
    Galli, A
    Orlandi, E
    Lazzarino, M
    Cazzola, M
    BLOOD, 2003, 102 (11) : 419A - 420A
  • [36] Tp53 codon 72 and MDM2 SNP309 polymorphisms in pancreatic cancer
    Hori, Yasuki
    Miyabe, Katsuyuki
    Yoshida, Michihiro
    Nakazawa, Takahiro
    Hayashi, Kazuki
    Naitoh, Itaru
    Shimizu, Shuya
    Kondo, Hiromu
    Nishi, Yuji
    Umemura, Shuichiro
    Ohara, Hirotaka
    Joh, Takashi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 213 - 214
  • [37] Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
    Kyndi, M
    Alsner, J
    Hansen, LL
    Sorensen, FB
    Overgaard, J
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S54 - S54
  • [38] Recurrence risk evaluation in stage IB gastric cancer with TP53 codon 72 polymorphism.
    Nishizuka, Satoshi
    Ohmori, Yukimi
    Iwaya, Takeshi
    Koeda, Keisuke
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] TP53 codon 72 polymorphism in oral squamous cell carcinoma.
    Drummond, SN
    De Marco, L
    Pordeus, IA
    Barbosa, AA
    Gomez, RS
    JOURNAL OF DENTAL RESEARCH, 2003, 82 : 131 - 131
  • [40] TP53 GENE POLYMORPHISM AT CODON 72 AS A RESPONSE PREDICTOR FOR NEOADJUVANT CHEMOTHERAPY
    Vieira, Jussane
    Nazario, Afonso
    Pesquero, Joao
    CANCER RESEARCH, 2024, 84 (09)